- Home
- BRTX vs CLRO Comparison
BRTX vs CLRO Comparison
Compare BRTX & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- CLRO
- Stock Information
- Founded
- BRTX 1997
- CLRO 1983
- Country
- BRTX United States
- CLRO United States
- Employees
- BRTX N/A
- CLRO N/A
- Industry
- BRTX Managed Health Care
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- BRTX Health Care
- CLRO Technology
- Exchange
- BRTX Nasdaq
- CLRO Nasdaq
- Market Cap
- BRTX 12.6M
- CLRO 12.5M
- IPO Year
- BRTX N/A
- CLRO N/A
- Fundamental
- Price
- BRTX $1.61
- CLRO $5.26
- Analyst Decision
- BRTX Strong Buy
- CLRO
- Analyst Count
- BRTX 1
- CLRO 0
- Target Price
- BRTX $18.00
- CLRO N/A
- AVG Volume (30 Days)
- BRTX 253.7K
- CLRO 33.9K
- Earning Date
- BRTX 08-12-2025
- CLRO 08-14-2025
- Dividend Yield
- BRTX N/A
- CLRO 135.38%
- EPS Growth
- BRTX N/A
- CLRO N/A
- EPS
- BRTX N/A
- CLRO N/A
- Revenue
- BRTX $391,000.00
- CLRO $10,077,000.00
- Revenue This Year
- BRTX $391.52
- CLRO N/A
- Revenue Next Year
- BRTX $3.50
- CLRO N/A
- P/E Ratio
- BRTX N/A
- CLRO N/A
- Revenue Growth
- BRTX 161.54
- CLRO N/A
- 52 Week Low
- BRTX $1.21
- CLRO $4.35
- 52 Week High
- BRTX $2.55
- CLRO $21.00
- Technical
- Relative Strength Index (RSI)
- BRTX 46.78
- CLRO 37.58
- Support Level
- BRTX $1.57
- CLRO $4.98
- Resistance Level
- BRTX $1.72
- CLRO $8.91
- Average True Range (ATR)
- BRTX 0.13
- CLRO 0.86
- MACD
- BRTX -0.01
- CLRO 0.00
- Stochastic Oscillator
- BRTX 20.65
- CLRO 6.62
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.